vs

Side-by-side financial comparison of Kimco Realty (KIM) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $558.0M, roughly 1.7× Kimco Realty). Kimco Realty runs the higher net margin — 29.8% vs -15.2%, a 45.0% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 4.0%). Over the past eight quarters, Kimco Realty's revenue compounded faster (5.6% CAGR vs 0.4%).

Kimco Realty Corporation, headquartered in Jericho, New York, is a real estate investment trust that invests in shopping centers.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

KIM vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.7× larger
XRAY
$961.0M
$558.0M
KIM
Growing faster (revenue YoY)
XRAY
XRAY
+2.2% gap
XRAY
6.2%
4.0%
KIM
Higher net margin
KIM
KIM
45.0% more per $
KIM
29.8%
-15.2%
XRAY
Faster 2-yr revenue CAGR
KIM
KIM
Annualised
KIM
5.6%
0.4%
XRAY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
KIM
KIM
XRAY
XRAY
Revenue
$558.0M
$961.0M
Net Profit
$166.3M
$-146.0M
Gross Margin
46.1%
Operating Margin
37.2%
-14.5%
Net Margin
29.8%
-15.2%
Revenue YoY
4.0%
6.2%
Net Profit YoY
23.7%
66.0%
EPS (diluted)
$0.46
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KIM
KIM
XRAY
XRAY
Q1 26
$558.0M
Q4 25
$542.5M
$961.0M
Q3 25
$535.9M
$904.0M
Q2 25
$525.2M
$936.0M
Q1 25
$536.6M
$879.0M
Q4 24
$525.4M
$905.0M
Q3 24
$507.6M
$951.0M
Q2 24
$500.2M
$984.0M
Net Profit
KIM
KIM
XRAY
XRAY
Q1 26
$166.3M
Q4 25
$151.2M
$-146.0M
Q3 25
$137.8M
$-427.0M
Q2 25
$163.0M
$-45.0M
Q1 25
$132.8M
$20.0M
Q4 24
$166.0M
$-430.0M
Q3 24
$136.0M
$-494.0M
Q2 24
$119.7M
$-4.0M
Gross Margin
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
46.1%
Q3 25
48.8%
Q2 25
52.4%
Q1 25
53.0%
Q4 24
49.3%
Q3 24
52.1%
Q2 24
51.9%
Operating Margin
KIM
KIM
XRAY
XRAY
Q1 26
37.2%
Q4 25
36.4%
-14.5%
Q3 25
34.9%
-24.1%
Q2 25
39.2%
-13.7%
Q1 25
33.6%
7.2%
Q4 24
31.7%
-56.2%
Q3 24
33.7%
-48.6%
Q2 24
32.1%
5.1%
Net Margin
KIM
KIM
XRAY
XRAY
Q1 26
29.8%
Q4 25
27.9%
-15.2%
Q3 25
25.7%
-47.2%
Q2 25
31.0%
-4.8%
Q1 25
24.8%
2.3%
Q4 24
31.6%
-47.5%
Q3 24
26.8%
-51.9%
Q2 24
23.9%
-0.4%
EPS (diluted)
KIM
KIM
XRAY
XRAY
Q1 26
$0.46
Q4 25
$-0.74
Q3 25
$-2.14
Q2 25
$-0.22
Q1 25
$0.10
Q4 24
$-2.09
Q3 24
$-2.46
Q2 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KIM
KIM
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$10.4B
$1.3B
Total Assets
$19.6B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
$211.6M
$326.0M
Q3 25
$159.3M
$363.0M
Q2 25
$226.6M
$359.0M
Q1 25
$131.3M
$398.0M
Q4 24
$688.6M
$272.0M
Q3 24
$789.0M
$296.0M
Q2 24
$126.4M
$279.0M
Total Debt
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
$7.7B
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$8.0B
$1.7B
Q3 24
Q2 24
Stockholders' Equity
KIM
KIM
XRAY
XRAY
Q1 26
$10.4B
Q4 25
$10.4B
$1.3B
Q3 25
$10.5B
$1.5B
Q2 25
$10.5B
$2.0B
Q1 25
$10.6B
$2.0B
Q4 24
$10.7B
$1.9B
Q3 24
$10.5B
$2.5B
Q2 24
$10.6B
$3.1B
Total Assets
KIM
KIM
XRAY
XRAY
Q1 26
$19.6B
Q4 25
$19.7B
$5.4B
Q3 25
$19.9B
$5.7B
Q2 25
$19.8B
$6.1B
Q1 25
$19.7B
$6.0B
Q4 24
$20.3B
$5.8B
Q3 24
$20.1B
$6.6B
Q2 24
$19.5B
$6.9B
Debt / Equity
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
0.74×
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.75×
0.90×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KIM
KIM
XRAY
XRAY
Operating Cash FlowLast quarter
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
$258.4M
$101.0M
Q3 25
$332.4M
$79.0M
Q2 25
$305.4M
$48.0M
Q1 25
$223.8M
$7.0M
Q4 24
$239.5M
$87.0M
Q3 24
$295.9M
$141.0M
Q2 24
$294.1M
$208.0M
Free Cash Flow
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
$60.0M
Q3 25
$40.0M
Q2 25
$16.0M
Q1 25
$205.4M
$-12.0M
Q4 24
$36.0M
Q3 24
$98.0M
Q2 24
$156.0M
FCF Margin
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
6.2%
Q3 25
4.4%
Q2 25
1.7%
Q1 25
38.3%
-1.4%
Q4 24
4.0%
Q3 24
10.3%
Q2 24
15.9%
Capex Intensity
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
0.0%
4.3%
Q3 25
0.0%
4.3%
Q2 25
0.0%
3.4%
Q1 25
3.4%
2.2%
Q4 24
5.6%
Q3 24
4.5%
Q2 24
5.3%
Cash Conversion
KIM
KIM
XRAY
XRAY
Q1 26
Q4 25
1.71×
Q3 25
2.41×
Q2 25
1.87×
Q1 25
1.69×
0.35×
Q4 24
1.44×
Q3 24
2.18×
Q2 24
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KIM
KIM

Revenues from rental properties, net$552.8M99%
Management and other fee income$5.2M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons